Echinoderm microtubule-associated protein-like 4 – anaplastic lymphoma kinase (EML4-ALK) gene fusions are prevalent in lung cancer and treatment with ALK inhibitors is a part of conventional care (Recondo et al. 2018). This evidence concerns the gene ALK and lung cancer.